Archived Comments for:
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
The original paper was published with an error in Table 1. The footnote of this table contains the following definition of neuropathic pain:
Fabry neuropathic pain meets the ‘characteristic clinical criteria’ if there is neuropathic pain in hands and/or feet, starting before age 18 years or increasing with heat, fever. Quantitative sensory testing (QST) reveals a decreased cold detection threshold and the intraepidermal nerve fiber density is increased. There is no other cause for neuropathic pain.
This should be: Quantitative sensory testing (QST) reveals an increased cold detection threshold and the intraepidermal nerve fiber density is decreased.
Orphanet Journal of Rare Diseases
Error in Table 1
19 June 2015
The original paper was published with an error in Table 1. The footnote of this table contains the following definition of neuropathic pain:Fabry neuropathic pain meets the ‘characteristic clinical criteria’ if there is neuropathic pain in hands and/or feet, starting before age 18 years or increasing with heat, fever. Quantitative sensory testing (QST) reveals a decreased cold detection threshold and the intraepidermal nerve fiber density is increased. There is no other cause for neuropathic pain.
This should be: Quantitative sensory testing (QST) reveals an increased cold detection threshold and the intraepidermal nerve fiber density is decreased.
Competing interests
None declared